(c) 2024 PillSync.com

Pulmonary Hypertension tadalafil 20 MG Oral Tablet Alyq

1 INDICATIONS AND USAGE ALYQ™ is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional Class II - III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases (23%). ( 1.1 ) 1.1 Pulmonary Arterial Hypertension ALYQ™ is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional Class II – III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases (23%).

teva pharmaceuticals usa, inc.


4 years ago OVAL ORANGE 3334 Pulmonary Hypertension tadalafil 20 MG Oral Tablet Alyq

OVAL ORANGE 3334

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied ALYQâ„¢ (

TADALAFIL tablets USP) is supplied as follows: 20 mg orange, oval-shaped, film-coated tablets (not scored), debossed with "TEVA" on one side and with "3334" on the other side of the tablet in bottles of 60 (NDC 0093-3334-06). 16.2 Storage Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Keep out of reach of children.


More pills like OVAL 3334












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site